跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,516 条关于
“Jiangsu Alphamab Biopharmaceutical”
全部
3,516
临床试验
96
药物
388
机构
373
资讯
2,659
上个月
Pathos AI Licenses Experimental Triple-Negative Breast Cancer Drug from China's Alphamab in $125 Million Deal
去年
Advancements in HER2-Positive Gastric Cancer Treatment Landscape
去年
Alphamab Oncology's JSKN033 Shows Promise in HER2-Expressing Solid Tumors
去年
Recbio Initiates Phase III Trial of REC610 Shingles Vaccine in China
10个月前
Alphamab Oncology's JSKN003 Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Cancer
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for SCLC in China
去年
Alphamab Oncology Retracts Announcement on JSKN033 Clinical Trial Inclusion
2年前
PharmaEssentia Launches BESREMi® in Singapore for Polycythemia Vera Treatment
去年
Alphamab Oncology's HER2-Targeting ADC JSKN003 Receives FDA Orphan Drug Designation for Gastric Cancer
去年
Chinese Drugmaker Jiangsu Hengrui Becomes World's Top Clinical Trial Sponsor as China Transforms Global R&D Landscape
第 1 页，共 266 页
上一页
下一页
